The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Scientists at deCODE genetics/Amgen have identified associations between bipolar disorder and rare loss-of-function variants ...

UCLA Health researchers say study findings uncover Huntington's disease mechanisms and pave new ways to develop treatments.

The Ontario Brain Institute (OBI) is pleased to announce a joint new initiative with EpiSign Inc., paving the way for improved diagnosis and care for people with rare neurological genetic disorders.

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between bipolar disorder and rare loss-of-function variants in two genes.

POLG-related diseases disrupt the function of the mitochondria, or "powerhouses" of the cell — starving them of energy.

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...

It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argue authors of a new essay.

Baylor Genetics, a clinical diagnostic laboratory celebrating a decade at the forefront of genetic testing, today shared ...

An international team, led by the Immunogenetics Research Laboratory (IRLab) at the University of the Basque Country (UPV/EHU ...